https://kybio.tech.blog/2019/05/18/how-cell-therapies-require-new-change/2019-05-18T16:28:09+00:00monthlyhttps://kybio.tech.blog/2019/05/17/refueling-innovations-in-vaccines/2019-05-17T20:42:57+00:00monthlyhttps://kybio.tech.blog/2019/01/11/resmeds-acquisition-of-propellor/2019-01-11T07:18:13+00:00monthlyhttps://kybio.tech.blog/2019/01/08/baselga-takes-astrazenecas-cancer-rnd/2019-01-08T00:05:36+00:00monthlyhttps://kybio.tech.blog/2018/12/13/crispr-the-promise-of-gene-editing/2018-12-13T23:18:31+00:00monthlyhttps://kybio.tech.blog/2018/12/12/oral-biologics-pipe-dream-technology-platform/2018-12-12T23:26:05+00:00monthlyhttps://kybio.tech.blog/2018/12/07/funding-for-a-migraine-drug-taken-via-nasal-delivery/2018-12-07T07:26:15+00:00monthlyhttps://kybio.tech.blog/2018/12/05/gilead-nash-drug-development-with-new-phase-3-fda-rules/2018-12-07T06:38:12+00:00monthlyhttps://kybio.tech.blog/2018/12/05/the-journey-begins/2018-12-05T21:35:18+00:00monthlyhttps://kybio.tech.blog/contact/https://kybio.tech.blog/wp-content/uploads/2018/12/person-smartphone-office-table.jpegPlaceholder Image2018-12-05T21:35:18+00:00weekly0.6https://kybio.tech.blogdaily1.02019-05-18T16:28:09+00:00